Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Photobiomodulation is safe for skin rejuvenation, even for those with a cancer history.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Laser-assisted drug delivery is generally safe with mostly mild side effects.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Stem cell therapy helps heal burn wounds faster in animals.

Nanoparticles added to natural materials like cellulose and collagen can improve cell growth and wound healing, but more testing is needed to ensure they're safe and effective.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Many people experience hair loss after weight loss surgery, especially younger women, and it's linked to lower levels of zinc, folic acid, and ferritin.

People undergoing chemotherapy need better support and information to cope with hair loss.

5 mg/mL of triamcinolone acetonide is most effective for hair regrowth with fewer side effects.

Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.

Neuropathic pain is common in long COVID patients, especially those with depression or severe COVID-19.

Women with hair loss may benefit from higher iron levels.

The review concluded that reporting on PRP therapy is often incomplete, leading to uncertainty about its effectiveness.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Polynucleotides might work well in esthetic medicine, but more research is needed.